Clinical Preventive Service Recommendation

Ovarian Cancer

Ovarian Cancer, Women

The AAFP recommends against screening for ovarian cancer in women. (2012)

(Grade: D recommendation)
Grade Definition: http://www.uspreventiveservicestaskforce.org/uspstf/grades.htm#drec(www.uspreventiveservicestaskforce.org)
Clinical Considerations: http://www.uspreventiveservicestaskforce.org/3rduspstf/ovariancan/ovcanrs.htm#clinical(www.uspreventiveservicestaskforce.org)

Ovarian Cancer/BRCA Mutation Testing

The AAFP recommends that women whose family history is associated with an increased risk for deleterious mutations in BRCA1 or BRCA2 genes be referred for genetic counseling and evaluation for BRCA testing. (2005)

(Grade: B recommendation)
Grade Definition: http://www.uspreventiveservicestaskforce.org/uspstf/grades.htm(www.uspreventiveservicestaskforce.org)
Clinical Consideration: http://www.uspreventiveservicestaskforce.org/uspstf/uspsbrgen.htm(www.uspreventiveservicestaskforce.org)

Ovarian Cancer/BRCA Mutation Testing

The AAFP recommends against routine referral for genetic counseling or routine breast cancer susceptibility gene (BRCA) testing for women whose family history is not associated with increased risk for deleterious mutations in breast cancer susceptibility gene 1 (BRCA1) or breast cancer susceptibility gene 2 (BRCA2). (2005)

(Grade: D recommendation)
Grade Definition: http://www.uspreventiveservicestaskforce.org/uspstf/grades.htm(www.uspreventiveservicestaskforce.org)
Clinical Consideration: http://www.uspreventiveservicestaskforce.org/uspstf/uspsbrgen.htm(www.uspreventiveservicestaskforce.org)